SCHEMBL7061111

SCHEMBL7061111

CC(=O)OC(C)C(=O)OC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.46
EPHX1 P07099 2/20 0.41
NAAA Q02083 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 3/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
CYP2C19 P33261 1/20 0.35
GAA P10253 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
HSD17B10 Q99714 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4677963 0.98 CYP19A1 (0.44) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL22572771 0.90 TSHR (0.41) CYP19A1TSHRSMN1; SMN2HSD17B10MEN1
SCHEMBL23323307 0.85 CYP19A1 (0.46) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL7061110 0.85 CYP19A1 (0.46) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL30051057 0.84 CYP19A1 (0.45) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL4677958 0.83 CYP19A1 (0.44) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL4186627 0.83 CYP19A1 (0.42) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL6520402 0.82 CYP19A1 (0.44) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL22357761 0.81 CYP19A1 (0.49) CYP19A1EPHX1NAAAL3MBTL1TSHR
SCHEMBL27437517 0.81 CYP19A1 (0.49) CYP19A1EPHX1NAAAL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216258-A1 Condensed heterocylic compounds and herbicides containing them as active ingredients SUMITOMO CHEMICAL COMPANY, LIMITED 2003-11-20 US disclosed
US-6586368-B1 Benzofuran derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-07-01 US disclosed
EP-1112268-A1 CONDENSED HETEROCYCLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2001-07-04 EP disclosed
WO-2000015633-A1 CONDENSED HETEROCYLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216258-A1 Condensed heterocylic compounds and herbicides containing them as active ingredients CBR3, CBR1, HAAO CYP19A1 951/4885EPHX1 236/4885NAAA 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.